Home Shares Halma shares surge following strong interim update

Halma shares surge following strong interim update

1
Halma shares surge following strong interim update

Halma plc (LON: HLMA) have seen their shares surge on Tuesday morning after the firm lifted its payout after strong interim results were reported.

Halma are are a firm which make products for hazard detection and life protection, that provide infrastructure, medical, environmental and analysis products.

Halma updated shareholders positively saying that it had seen “good organic and acquired growth”, which led to the interim payout rise.

Shares in Halma surged 11.51% to 2,119p. 19/11/19 10:31BST.

For the six months to September 30, Halma reported pretax profit of £105.8 million, up 12% from £94.5 million one year prior.

Revenue increased by 12% year-on-year to £653.7 million from £585.5 million.

“We grew revenue in all four major regions, with organic constant currency revenue growth in our four major regions and in all of our business sectors. This was further supported by a positive contribution from acquisitions and by favourable currency translation,” Halma said.

“Since the period end, order intake has continued to be ahead of revenue and order intake last year. Halma remains on track to make further progress in the second half of the year and deliver another good full year performance,” Halma Chief Executive Andrew Williams said.

“Our strong purpose and culture, our portfolio and geographic diversity together with our agile business model are enabling us to deliver a good performance in varied market conditions and to sustain growth and returns over the longer term.” Williams concluded.

Additionally, the FTSE100 (INDEXFTSE: UKX) listed firm saw strong growth in the USA, which is its biggest consumer base.

In the US there was a 15% rise in yearly interim revenue to £248.8 million, where as UK and European revenue grew 9% to £105.2 million and £135.5 million respectively.

In the medical and pharmaceuticals industry, the industry titans continue to dominate. Pfizer (NYSE: PFE) and GSK (LON: GSK) have reported strong quarterly updates.

Additionally, it was reported on Friday that Roche (LON: GSK) had acquired US based Promedior.

Halma has upped its interim dividend payment by 7.0% to 6.54p per share from 6.11p a year ago.